- All sections
- C - Chemistry; metallurgy
- C07K - Peptides
- C07K 16/06 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies from serum
Patent holdings for IPC class C07K 16/06
Total number of patents in this class: 1038
10-year publication summary
|
52
|
58
|
73
|
88
|
133
|
106
|
87
|
107
|
82
|
23
|
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Takeda Pharmaceutical Company Limited | 2961 |
37 |
| Cytiva BioProcess R&D AB | 287 |
34 |
| Hoffmann-La Roche Inc. | 3060 |
32 |
| Genentech, Inc. | 3742 |
31 |
| Amgen Inc. | 3779 |
31 |
| Regeneron Pharmaceuticals, Inc. | 3650 |
31 |
| F. Hoffmann-La Roche AG | 7958 |
30 |
| CSL Behring AG | 159 |
28 |
| Biotest AG | 111 |
20 |
| Bristol-myers Squibb Company | 5080 |
12 |
| Plasma Technologies, LLC | 30 |
12 |
| AbbVie Biotechnology Ltd. | 185 |
11 |
| Janssen Biotech, Inc. | 1347 |
11 |
| ADMA Biomanufacturing, LLC | 25 |
11 |
| Momenta Pharmaceuticals, Inc. | 302 |
10 |
| Bio-Rad Laboratories, Inc. | 1592 |
9 |
| Merck Sharp & Dohme LLC | 3689 |
9 |
| Wyeth LLC | 691 |
8 |
| EMD Millipore Corporation | 657 |
8 |
| The Johns Hopkins University | 5377 |
8 |
| Other owners | 655 |